Vivas C A, Hickey D P, Jordan M L, O'Donovan R M, Lutins J, Shapiro R, Starzl T E, Hakala T R
Department of Surgery, University of Pittsburgh, Pennsylvania.
J Urol. 1992 Apr;147(4):990-3. doi: 10.1016/s0022-5347(17)37443-8.
Between January 1982 and August 1989, cadaveric renal transplantation was performed in 22 patients 65 years old or older. Mean recipient age was 68 years (range 65 to 73 years). There were 17 men and 5 women. Additional risk factors included retransplantation (3 patients), high (greater than 30%) panel reactive antibody (4) and diabetes (1). All patients received cyclosporine as part of the immunosuppressive regimen. The 3-year actuarial patient and allograft survival rates were 89% and 71%, respectively. There were 6 graft losses due to chronic rejection (2 patients), renal vein thrombosis (1), myocardial infarction (1), withdrawal of immunosuppression because of sepsis (1) and primary nonfunction (1). Of the 16 patients with a functioning graft 12 currently have a serum creatinine of less than 2.0 mg./dl. These results suggest that cadaveric renal transplantation is an acceptable form of treatment for patients older than 65 years with end stage renal disease.
1982年1月至1989年8月期间,对22例65岁及以上患者进行了尸体肾移植。受者平均年龄为68岁(范围65至73岁)。其中男性17例,女性5例。其他危险因素包括再次移植(3例患者)、高群体反应性抗体(大于30%,4例)和糖尿病(1例)。所有患者均接受环孢素作为免疫抑制方案的一部分。3年精算患者和移植物存活率分别为89%和71%。有6例移植物丢失,原因分别为慢性排斥(2例患者)、肾静脉血栓形成(1例)、心肌梗死(1例)、因败血症停用免疫抑制(1例)和原发性无功能(1例)。在16例移植肾功能良好的患者中,12例目前血清肌酐低于2.0mg./dl。这些结果表明,尸体肾移植是65岁以上终末期肾病患者可接受的一种治疗方式。